Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Jul;100(1):8-17.
doi: 10.1016/s0029-7844(02)02019-7.

Management of uterine leiomyomata: what do we really know?

Evan R Myers  1 , Matthew D Barber, Tara Gustilo-Ashby, Grace Couchman, David B Matchar, Douglas C McCrory
Affiliations
Review

Management of uterine leiomyomata: what do we really know?

Evan R Myers et al. Obstet Gynecol. 2002 Jul.

Abstract

Objective: To systematically review the literature on the surgical and nonsurgical management of uterine leiomyomata.

Data sources: Published literature in English on the management of uterine leiomyomata published from 1975 through 2000 was identified in MEDLINE, CINAHL, CancerLit, EMBASE, HealthSTAR, and the Cochrane Database of Systematic Reviews. Search terms included "leiomyomata," "fibroids," "hysterectomy," and "myomectomy."

Study selection: Study designs considered included controlled trials, prospective trials with historical controls, prospective or retrospective cohort studies, and series with at least 20 cases. Original research studies or relevant reviews were included if the study population included women with uterine leiomyomata, and data were provided relevant to one or more of nine prespecified research questions.

Tabulation, integration, and results: Inconsistency in reporting of severity of symptoms, uterine anatomy, and response to therapy prevented meaningful comparison of studies in most cases, and prevented performance of meta-analysis in all cases. This was true of both surgical and nonsurgical treatments.

Conclusion: The available evidence on the management of uterine leiomyomata is of poor quality. Patients, clinicians, and policymakers do not have the data needed to make informed decisions about appropriate treatment. Given the prevalence of this condition and its substantial impact on women's lives, obtaining these data should be a high research priority.

PubMed Disclaimer